Biblio
2 resultats trouvés
Filtres: Mot-clé is Global burden of disease [Clear All Filters]
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES. 12
.
2019. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia. JOURNAL OF INFECTION. 79:300-311.
.
2019.